Wuhan YZY Biopharma Co., Ltd. (02496)
Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases. The company develops various product candidates for the treatment of malignant ascites, malignant pleural effusion, solid tumors, pancreatic cancer, hepatocellular carcinoma, and other advanced solid tumors; wAMD, DME, and oth
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
